A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

NCT04929379 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathies

Interventions

DRUG: Fenofibrate
OTHER: Placebo

Sponsor

Alessandro Doria

Collaborators

[object Object]
[object Object]